Indication

Treatment-naive Advanced Non-small Cell Lung Cancer

1 clinical trial

1 product

Clinical trial

A Phase III, Randomized, Double-blind, Placebo-controlled, Multi-center Clinical Study to Evaluate the Efficacy and Safety of Toripalimab Injection (JS001) or Placebo Combined With First-line Standard Chemotherapy in Treatment-naive Advanced Non-small Cell Lung Cancer (NSCLC)

Status: Completed, Estimated PCD: 2022-08-31

Product